☰

Avadhut D. Joshi, Ph.D. - Publications

Affiliations: 
2006 University of Nebraska Medical Center, Omaha, NE, United States 
Area:
Oncology, Cell Biology
Tree Info Similar researchers PubMed Report error

24 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Joshi AD, Botham RC, Schlein LJ, Roth HS, Mangraviti A, Borodovsky A, Tyler B, Joslyn S, Looper JS, Podell M, Fan TM, Hergenrother PJ, Riggins GJ. Synergistic and targeted therapy with a procaspase-3 activator and temozolomide extends survival in glioma rodent models and is feasible for the treatment of canine malignant glioma patients. Oncotarget. 8: 80124-80138. PMID 29113289 DOI: 10.18632/Oncotarget.19085  0.339
2015 Wicks RT, Azadi J, Mangraviti A, Zhang I, Hwang L, Joshi A, Bow H, Hutt-Cabezas M, Martin KL, Rudek MA, Zhao M, Brem H, Tyler BM. Local delivery of cancer-cell glycolytic inhibitors in high-grade glioma. Neuro-Oncology. 17: 70-80. PMID 25053853 DOI: 10.1093/Neuonc/Nou143  0.343
2015 Joshi AD, Botham RC, Roth HS, Fan TM, Tarasow TM, Hergenrother PJ, Riggins GJ. Abstract 3620: An oral procaspase activating drug, PAC-1, shows preclinical promise for glioblastoma therapy Cancer Research. 75: 3620-3620. DOI: 10.1158/1538-7445.Am2015-3620  0.396
2013 Mittal AK, Chaturvedi NK, Rohlfsen RA, Gupta P, Joshi AD, Hegde GV, Bociek RG, Joshi SS. Role of CTLA4 in the proliferation and survival of chronic lymphocytic leukemia. Plos One. 8: e70352. PMID 23936412 DOI: 10.1371/Journal.Pone.0070352  0.71
2012 Joshi AD, Loilome W, Siu IM, Tyler B, Gallia GL, Riggins GJ. Evaluation of tyrosine kinase inhibitor combinations for glioblastoma therapy. Plos One. 7: e44372. PMID 23056179 DOI: 10.1371/Journal.Pone.0044372  0.358
2010 Seltzer MJ, Bennett BD, Joshi AD, Gao P, Thomas AG, Ferraris DV, Tsukamoto T, Rojas CJ, Slusher BS, Rabinowitz JD, Dang CV, Riggins GJ. Inhibition of glutaminase preferentially slows growth of glioma cells with mutant IDH1. Cancer Research. 70: 8981-7. PMID 21045145 DOI: 10.1158/0008-5472.Can-10-1666  0.377
2010 Clark EM, Joshi DS, Grimm AB, Joshi AD, Wang P, Joshi SS. Ultrastructural basis of enhanced antitumor cytotoxicity of cord blood-derived CTLs: a comparative analysis with peripheral blood and bone marrow. International Journal of Oncology. 37: 645-53. PMID 20664933 DOI: 10.3892/Ijo-00000713  0.531
2010 Rao SK, Edwards J, Joshi AD, Siu IM, Riggins GJ. A survey of glioblastoma genomic amplifications and deletions. Journal of Neuro-Oncology. 96: 169-79. PMID 19609742 DOI: 10.1007/S11060-009-9959-4  0.383
2010 Loilome W, Joshi AD, Rhys CMJA, Piccirillo SGM, Vescovi AL, Gallia GL, Riggins GJ. Erratum to: Glioblastoma cell growth is suppressed by disruption of fibroblast growth factor pathway signaling Journal of Neuro-Oncology. 97: 459-459. DOI: 10.1007/S11060-010-0155-3  0.366
2009 Loilome W, Joshi AD, ap Rhys CM, Piccirillo S, Vescovi AL, Angelo VL, Gallia GL, Riggins GJ. Glioblastoma cell growth is suppressed by disruption of Fibroblast Growth Factor pathway signaling. Journal of Neuro-Oncology. 94: 359-66. PMID 19340397 DOI: 10.1007/S11060-009-9885-5  0.409
2008 Hegde GV, Peterson KJ, Emanuel K, Mittal AK, Joshi AD, Dickinson JD, Kollessery GJ, Bociek RG, Bierman P, Vose JM, Weisenburger DD, Joshi SS. Hedgehog-induced survival of B-cell chronic lymphocytic leukemia cells in a stromal cell microenvironment: a potential new therapeutic target. Molecular Cancer Research : McR. 6: 1928-36. PMID 19074837 DOI: 10.1158/1541-7786.Mcr-08-0142  0.732
2008 Joshi SS, Mittal AK, Wang P, Joshi AD, Vu E, Wang X. Differential gene expression in murine large cell B-cell lymphoma metastatic variants. International Immunopharmacology. 8: 1257-63. PMID 18602072 DOI: 10.1016/J.Intimp.2008.05.007  0.717
2008 Hegde GV, Munger CM, Emanuel K, Joshi AD, Greiner TC, Weisenburger DD, Vose JM, Joshi SS. Targeting of sonic hedgehog-GLI signaling: a potential strategy to improve therapy for mantle cell lymphoma. Molecular Cancer Therapeutics. 7: 1450-60. PMID 18524848 DOI: 10.1158/1535-7163.Mct-07-2118  0.77
2007 Joshi AD, Clark EM, Wang P, Munger CM, Hegde GV, Sanderson S, Dave HP, Joshi SS. Immunotherapy of human neuroblastoma using umbilical cord blood-derived effector cells. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 2: 202-12. PMID 18040845 DOI: 10.1007/S11481-006-9038-Y  0.751
2007 Joshi AD, Hegde GV, Dickinson JD, Mittal AK, Lynch JC, Eudy JD, Armitage JO, Bierman PJ, Bociek RG, Devetten MP, Vose JM, Joshi SS. ATM, CTLA4, MNDA, and HEM1 in high versus low CD38 expressing B-cell chronic lymphocytic leukemia. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 5295-304. PMID 17875758 DOI: 10.1158/1078-0432.Ccr-07-0283  0.696
2007 Mittal AK, Hegde GV, Aoun P, Bociek RG, Dave BJ, Joshi AD, Sanger WG, Weisenburger DD, Joshi SS. Molecular basis of aggressive disease in chronic lymphocytic leukemia patients with 11q deletion and trisomy 12 chromosomal abnormalities. International Journal of Molecular Medicine. 20: 461-9. PMID 17786276 DOI: 10.3892/Ijmm.20.4.461  0.662
2007 Joshi AD, Dickinson JD, Hegde GV, Sanger WG, Armitage JO, Bierman PJ, Bociek RG, Devetten MP, Vose JM, Joshi SS. Bulky lymphadenopathy with poor clinical outcome is associated with ATM downregulation in B-cell chronic lymphocytic leukemia patients irrespective of 11q23 deletion. Cancer Genetics and Cytogenetics. 172: 120-6. PMID 17213020 DOI: 10.1016/J.Cancergencyto.2006.07.010  0.598
2007 Mittal AK, Rohlfsen RA, Joshi AD, Hegde GV, Bociek RG, Joshi SS. Regulation of Chronic Lymphocytic Leukemia Cell Proliferation by CTLA4. Blood. 110: 1140-1140. DOI: 10.1182/Blood.V110.11.1140.1140  0.729
2007 Hegde G, Munger C, Emanuel K, Weisenburger D, Joshi A, Vose J, Joshi S. Targeting Conic Hedgehog-GLI Signaling for the Treatment of Mantle Cell Lymphoma Clinical Immunology. 123: S109. DOI: 10.1016/J.Clim.2007.03.490  0.742
2006 Dickinson JD, Joshi A, Iqbal J, Sanger W, Bierman PJ, Joshi SS. Genomic abnormalities in chronic lymphocytic leukemia influence gene expression by a gene dosage effect. International Journal of Molecular Medicine. 17: 769-78. PMID 16596259 DOI: 10.3892/Ijmm.17.5.769  0.533
2006 Hegde GV, Emanuel K, Joshi AD, Munger CM, Weisenburger DD, Vose JM, Joshi SS. Sonic Hedgehog Signaling in Mantle Cell Lymphoma. Blood. 108: 2046-2046. DOI: 10.1182/Blood.V108.11.2046.2046  0.783
2005 Joshi AD, Dickinson JD, Lynch JC, Bierman PJ, Bociek GR, Devetten MP, Armitage JO, Joshi SS. Differential Expression of Hem1 and CTLA-4 in B-CLL Patients with High and Low CD38 Expression. Blood. 106: 2103-2103. DOI: 10.1182/Blood.V106.11.2103.2103  0.595
2004 Wang P, Munger CM, Joshi AD, Pirruccello SJ, Joshi SS. Cytotoxicity of cord blood derived Her2/neu-specific cytotoxic T lymphocytes against human breast cancer in vitro and in vivo. Breast Cancer Research and Treatment. 83: 15-23. PMID 14997051 DOI: 10.1023/B:Brea.0000010688.55353.A8  0.744
2004 Dickinson JD, Joshi A, Gilmore J, Bierman PJ, Warren S, Joshi SS. Gene Expression in CLL Cells Associated with Lymphadenopathy and Chromosome 11q23 Deletion. Blood. 104: 971-971. DOI: 10.1182/Blood.V104.11.971.971  0.598
Show low-probability matches.